Redwire vs. Rocket Lab: Which Industrials Stock Is a Better Buy in 2026?

Rocket Lab reported FY2025 revenue of about $601.8 million, up 38%, while Redwire generated nearly $335.4 million, up 10.3%; both remained loss-making. Rocket Lab had about $2.2 billion in net cash versus Redwire’s approximately $0.5 billion, but its P/S ratio was 54x compared with Redwire’s 6x. The article favors Redwire for its lower valuation and recent quarterly revenue growth of nearly 90%, while noting both companies’ cash burn, execution risks, and other uncertainties.

Analysis

The more useful distinction is execution optionality versus cash conversion—not simply which sales multiple is lower. RDW’s lower valuation gives it more room for multiple expansion if recent growth proves organic, repeatable, and converts into improving cash flow. But customer concentration makes contract timing or loss a disproportionately large earnings and valuation risk; the growth figure alone is not evidence of durable economics. RKLB’s premium embeds successful Neutron development and expansion beyond launch. A delay, failed test, or financing terms that dilute shareholders could compress that premium even if Electron operations remain intact. Conversely, Neutron progress and a clean Iridium transaction could sustain the premium and make a short position painful.

Second-order beneficiaries of a broader government-space buildout include LMT and NOC, which may retain an advantage in scale and contracting access; smaller suppliers’ upside depends on winning work without being squeezed on price. BMY and HMC are not investable read-throughs from the customer/partnership mentions absent material contract economics.

Near term, this is not a clean headline trade: the article gives inconsistent cash-flow figures and runway estimates, and the Iridium financing, consideration, and closing details need verification. Over 1–3 months, track RDW organic growth, backlog/concentration, and operating cash burn; for RKLB, track Neutron milestones and acquisition terms. Over 6–18 months, cash conversion and execution should matter more than reported sales growth. Contrarian point: RKLB’s premium may be justified by differentiated execution, while RDW’s discount may reflect genuine customer and cash-burn risk—not merely market neglect.

Key Decisions for Investors

• Prefer a small, conditional relative-value position—long RDW against short RKLB—only if RDW’s recent growth is confirmed as organic and backlog-supported. Size conservatively: RDW concentration risk and RKLB’s event-driven upside make this a high-volatility pair, not a valuation-arbitrage certainty.
• Do not initiate a standalone RDW long solely on the lower P/S. Require evidence of improving operating cash flow and stable customer concentration; worsening burn or a material contract loss falsifies the re-rating case.
• Treat RKLB as a milestone-driven position rather than a simple growth-stock short. Reassess after verified Neutron schedule updates and disclosed Iridium financing/dilution terms; a credible development path or favorable deal terms would invalidate the short leg.
• Before trading, reconcile the article’s conflicting free-cash-flow/runway numbers and verify the acquisition status, consideration, and funding from filings. Until then, keep exposure limited and avoid anchoring on the stated valuation multiples.